Content area

|
|

Genomisk medicin som forbrugervare

Forfatter(e)
Lasse Folkersen & Thomas Werge
Institut for Biologisk Psykiatri, Psykiatrisk Center Sct. Hans, Region Hovedstadens Psykiatri

Ugeskr Læger 2019;181:V11180789
Reference: 
Ugeskr Læger 2019;181:V11180789
Blad nummer: 

Lasse Folkersen & Thomas Werge:

Genomic medicine as consumer goods

Ugeskr Læger 2019;181:V11180789

In this review, current trends in personal genetics are covered. The main differences between the “classic” rare high-effect mutations vs. the combined effects of thousands of common, low-risk variants are outlined, and then we provide examples of possible clinical use of microarray-based genetic measurements of rare high-risk mutations, and diagnosis-specific polygenic risk scores. The aim of this review is to discuss the possible clinical relevance vs. the hyped and potentially harmful overinterpretations of direct-to-consumer genetics services.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Mette Jensen | 21/11
2 kommentarer
af Christian Søren Christiansen | 19/11
2 kommentarer
af Pål Ledaal | 18/11
3 kommentarer
af Hanne Pedersen | 17/11
1 Kommentar
af Mads Aage Toft Kristensen | 16/11
1 Kommentar
af Jens Lund Ahrenkiel | 15/11
1 Kommentar
af Nicolaj Markus Stilling | 15/11
2 kommentarer